Valuation: Shenzhen Salubris Pharmaceuticals Co., Ltd.

Capitalization 69.55B 10.18B 8.66B 7.98B 7.54B 14.04B 951B 14.34B 93.56B 36.75B 455B 38.22B 37.39B 1,623B P/E ratio 2025 *
105x
P/E ratio 2026 * 87.9x
Enterprise value 69.55B 10.18B 8.66B 7.98B 7.54B 14.04B 951B 14.34B 93.56B 36.75B 455B 38.22B 37.39B 1,623B EV / Sales 2025 *
15.4x
EV / Sales 2026 * 12.8x
Free-Float
37.38%
Yield 2025 *
-
Yield 2026 * -
1 day-0.84%
1 week-6.04%
Current month+1.76%
1 month+19.02%
3 months+16.29%
6 months+10.82%
Current year+25.91%
1 week 61.61
Extreme 61.61
67.3
1 month 52.3
Extreme 52.3
70.99
Current year 44.95
Extreme 44.95
70.99
1 year 32.81
Extreme 32.81
70.99
3 years 23.5
Extreme 23.5
70.99
5 years 20
Extreme 20
70.99
10 years 16.7
Extreme 16.7
70.99
Manager TitleAgeSince
Chief Executive Officer 53 2022-09-22
Director of Finance/CFO 52 2021-12-29
Chief Administrative Officer 50 2005-12-31
Director TitleAgeSince
Chairman 82 1998-11-02
Chairman 50 2022-09-22
Director/Board Member 50 2010-08-19
Change 5d. change 1-year change 3-years change Capi.($)
-0.84%-6.04%+87.13%+68.62% 10.27B
-0.16%-2.44%-2.09%+62.51% 42.69B
-1.55%-6.55%+55.93%+141.98% 35.29B
-1.50%+1.57%-17.22%+31.94% 10.68B
+0.76%+6.73%+6.16%+82.80% 9.9B
+0.43%0.00%+38.87%+114.68% 8.52B
+4.16%-18.83%+234.61%+450.21% 7.92B
-0.70%-1.60%+53.12%-9.28% 7.41B
+1.56%+7.00%+26.95%+64.56% 7.3B
+1.38%+4.84%+59.14%+346.25% 6.56B
Average +0.35%+0.92%+54.26%+135.43% 14.66B
Weighted average by Cap. -0.18%-0.96%+39.75%+114.38%

Financials

2025 *2026 *
Net sales 4.53B 663M 564M 520M 491M 914M 61.9B 934M 6.09B 2.39B 29.62B 2.49B 2.43B 106B 5.45B 797M 678M 625M 590M 1.1B 74.45B 1.12B 7.33B 2.88B 35.63B 2.99B 2.93B 127B
Net income 639M 93.56M 79.58M 73.33M 69.27M 129M 8.74B 132M 860M 338M 4.18B 351M 344M 14.91B 743M 109M 92.53M 85.27M 80.54M 150M 10.16B 153M 999M 393M 4.86B 408M 399M 17.34B
Net Debt - -
Logo Shenzhen Salubris Pharmaceuticals Co., Ltd.
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. is a China-based company, principally engaged in the research and development, manufacture and distribution of pharmaceuticals. The Company provides two categories of products: pharmaceutical preparation and bulk drugs. The Company is also engaged in the research and development, production and sales of cardiovascular medical devices. The Company distributes its products within domestic market and to overseas markets.
Employees
3,596
Date Price Change Volume
26-04-13 62.39 ¥ -0.84% 7,590,241
26-04-10 62.92 ¥ +0.08% 9,932,126
26-04-09 62.87 ¥ -2.19% 11,809,070
26-04-08 64.28 ¥ -0.96% 13,768,930
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
62.39CNY
Average target price
60.00CNY
Spread / Average Target
-3.83%

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 002294 Stock